IL6 and inflammatory bowel disease: IL-6/STAT3 was also demonstrated to be involved in metabolic reprogramming, to promote the progression from chronic colitis to CRC (Qu et al., 2017), and the COX-2/PGE2 pathway was also shown to contribute to inflammation and carcinogenesis in IBD.